![Steve Wrenn](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Aktive Positionen von Steve Wrenn
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Sonnest, Inc.
![]() Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2019 | - |
Gründer | 01.01.2019 | - |
Karriereverlauf von Steve Wrenn
Statistik
International
Vereinigte Staaten | 2 |
Operativ
Chief Tech/Sci/R&D Officer | 1 |
Founder | 1 |
Sektoral
Health Technology | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 1 |
---|---|
Sonnest, Inc.
![]() Sonnest, Inc. Medical SpecialtiesHealth Technology Sonnest, Inc. is a company that specializes in developing a contrast agent called Electrast™. The company is based in Baltimore, MD. The inspiration for Electrast™ began in 2015 through a collaboration between Dr. Wrenn, the company's Chief Scientific Officer, and Dr. Brett Angel, an electrophysiologist at Drexel University. Electrast™ is a voltage-activated ultrasound contrast agent that activates with ultrasound and the heart's local electric field if the heart tissue is perfused and viable. The company was founded in 2019 by Steve Wrenn, Brett Angel. The CEO is Peter Boyd. | Health Technology |
- Börse
- Insiders
- Steve Wrenn
- Erfahrung